Loading
Total declarations
Company
▲ Purchases (25 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Mar 2026 for Cumberland Pharmaceuticals INC, €4,368. Read the official filing
Filing timeline
BuySaleCaroline Young
Insider track record
Disclosed buys
25
Disclosed sells
0
T+90 hit rate
58%
T+90 mean return
+28.7%
Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Caroline Young: trading record in brief
All filings by Caroline Young on record concern Cumberland Pharmaceuticals Inc, in the capacity of board member. Between 17 March 2021 and 18 March 2026, the trades on record add up to 46 filings.
Purchases make up the whole of the open-market record (25 purchases, €912). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants.
Half of the purchases are above €37 and half below. Clusters matter here: 25 out of 25 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 20 March 2026 with a share grant (€4,368) in Cumberland Pharmaceuticals Inc. The most recent open-market purchase was published on 12 September 2025, 401 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 35 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Caroline Young
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
1,800 shares@ US$2.8018.9% of flowCommon StockSEC:0001087294-26-000036:0
4 shares@ US$2.360.0% of flowCommon StockSEC:0001087294-26-000008:0
6 shares@ US$2.800.1% of flowCommon StockSEC:0001087294-25-000029:0
6 shares@ US$3.310.1% of flowCommon StockSEC:0001684087-25-000008:0
4 shares@ US$3.540.1% of flowCommon StockSEC:0001684087-25-000004:0
6 shares@ US$3.440.1% of flowCommon StockSEC:0001628280-25-041989:0
Canonical exit: 30 Oct 2025 (T+90)
8 shares@ US$3.560.1% of flowCommon StockSEC:0001628280-25-039411:0
Canonical exit: 29 Sept 2025 (T+90)
4 shares@ US$5.200.1% of flowCommon StockSEC:0001628280-25-034820:0
Canonical exit: 31 Aug 2025 (T+90)
4 shares@ US$4.860.1% of flowCommon StockSEC:0001628280-25-029852:0
Canonical exit: 30 Jul 2025 (T+90)
4 shares@ US$4.240.1% of flowCommon StockSEC:0001628280-25-024355:0
Canonical exit: 30 Jun 2025 (T+90)
4 shares@ US$5.540.1% of flowCommon StockSEC:0001628280-25-016745:0
Canonical exit: 1 Jun 2025 (T+90)
1,000 shares@ US$5.1721.9% of flowCommon StockSEC:0001628280-25-013548:0
2,500 shares@ US$1.7118.2% of flowCommon StockSEC:0001628280-25-003181:0
15 shares@ US$1.330.1% of flowCommon StockSEC:0001628280-24-052610:0
Canonical exit: 2 Mar 2025 (T+90)
38 shares@ US$1.150.2% of flowCommon StockSEC:0001628280-24-050113:0
Canonical exit: 30 Jan 2025 (T+90)
31 shares@ US$1.270.2% of flowCommon StockSEC:0001628280-24-045334:0
Canonical exit: 30 Dec 2024 (T+90)
25 shares@ US$1.380.1% of flowCommon StockSEC:0001628280-24-042124:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-016075:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-016035:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-013685:0
25 shares@ US$1.520.2% of flowCommon StockSEC:0001214659-24-011873:0
1,000 shares@ US$1.717.3% of flowCommon StockSEC:0001214659-24-005221:0
72 shares@ US$1.690.5% of flowCommon StockSEC:0001214659-23-017033:0
55 shares@ US$1.850.4% of flowCommon StockSEC:0001214659-23-016104:0
55 shares@ US$1.890.5% of flowCommon StockSEC:0001214659-23-014544:0
25 of 46 declarations
